Clinical trials
Mortality clinical trials
Below are recruiting mortality clinical trials, each written for real people, not researchers. We’re tracking 155 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06531967Enrolling by invitation
Predicting survival in kidney transplant recipients
This study looks at factors that may help predict how long kidney transplant recipients live. If you are an adult who has received a single kidney transplant (your first one), you may be able to take part.
Phoenix, ArizonaAges 18–100 - NCT07575061Recruiting
Long-term study of survival factors in intestinal tuberculosis
This 15-year study follows patients with intestinal tuberculosis (a bacterial infection of the digestive tract) to understand what factors affect how long patients survive and live with this condition. The research may help doctors better predict outcomes and improve care for future patients.
Beijing, Beijing MunicipalityAges 18–100 - NCT07473999Recruiting
Vaccine protection in transplant recipients
This study looks at how well vaccines work in people who have received a bone marrow or solid organ transplant. Researchers will track infections and outcomes to understand vaccine effectiveness.
Pavia, LombardyAges Any age - NCT07025057Recruiting
Community program to reduce pregnancy-related health gaps
This trial tests a community-centered program to improve health care for pregnant and postpartum women in three Michigan counties and reduce racial disparities in pregnancy-related complications.
Grand Rapids, MichiganAges 18 years+ - NCT07300306Recruiting
Studying a new sepsis score in Turkish ICUs
This trial tests a new scoring system called SOFA-2 to better predict death and identify sepsis in adults staying in intensive care units (ICUs) in Turkey.
IstanbulAges 18 years+ - NCT05477277Recruiting
MRI testing during liver transplant evaluation
This study looks at whether having an MRI scan during liver transplant planning helps predict who may have worse outcomes or higher risk of death. It focuses on adults with severe liver disease who are already being considered for a transplant.
Phoenix, ArizonaAges 18 years+ - NCT07740304Recruiting
Blood flow test to predict survival in sepsis patients
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
Edirne, MerkezAges 18 years+ - NCT06742723RecruitingPhase 3
Study of baxdrostat and dapagliflozin for kidney disease and high blood pressure
This trial tests if combining baxdrostat with dapagliflozin helps protect kidney function and reduce heart risks in people with chronic kidney disease and high blood pressure. It's for adults who are already taking standard blood pressure medications.
Fairhope, AlabamaAges 18 years+ - NCT07715617Recruiting
Creating a prediction score for lung transplant or death in Alpha-1 Antitrypsin Deficiency
This study is creating a simple scoring system to predict who with Alpha-1 Antitrypsin Deficiency-related emphysema might need a lung transplant or die from the disease. Your medical records from 2010–2025 will help build this tool, with no extra tests or visits required.
BronAges 18 years+ - NCT04171830Enrolling by invitation
Screening for palliative needs in the last year of life
This trial uses a special tool to check if patients in the hospital have unmet needs for comfort and quality-of-life care. It is designed for patients who may be in their final year of life, helping doctors and nurses offer extra support sooner.
Brampton, OntarioAges Any age - NCT03116490Recruiting
Compares anesthesia types for recovery after hip fracture surgery
This study looks at whether using regional anesthesia or general anesthesia affects outcomes after hip fracture surgery in older adults. It may help doctors choose the safest anesthesia option for recovery and prognosis.
Wenzhou, ZhejiangAges 60 years+ - NCT03188796RecruitingPhase 3
High-dose vitamin D for ICU patients with low vitamin D
This trial tests whether giving a high dose of vitamin D3 can reduce death within 28 days for critically ill adults in the ICU who have very low vitamin D levels. It may help by correcting vitamin D deficiency, which the study team thinks could affect outcomes in serious illness.
EnzenbachAges 18–100 - NCT03335644Recruiting
Internet-based health study for people 15 and older
This study gathers health information through an online program. It may help researchers understand how diet and lifestyle affect health over time.
Bobigny, Seine Saint DenisAges 15 years+ - NCT03547232RecruitingPhase 4
Indomethacin given early to treat acute pancreatitis
This trial tests whether taking indomethacin (an anti-inflammatory medicine) early can improve outcomes in people with acute pancreatitis. You might be eligible if your pancreatitis is diagnosed soon and you meet specific lab, imaging, and safety requirements.
Beijing, Beijing MunicipalityAges 18–80 - NCT04020263RecruitingPhase 3
Levosimendan early treatment vs placebo for cardiogenic shock
This study tests whether giving levosimendan early (a heart-strengthening medicine) improves outcomes compared with placebo, on top of standard inotropic support, in people with cardiogenic shock. It mainly looks at whether patients have fewer serious complications or deaths.
Strasbourg, Bas-RhinAges 18 years+ - NCT04130789Recruiting
Personalized study for ICU patients with possible sepsis
This study looks at ICU patients in Swiss university hospitals to understand how to personalize care for people who meet sepsis criteria. It may help doctors better predict who is getting worse and tailor treatment plans.
BaselAges 18 years+ - NCT04145258RecruitingPhase 3
Stronger TB treatment for meningitis to reduce deaths
This trial tests if giving a stronger combination of TB drugs for meningitis can save more lives. It's for patients who have been diagnosed with tuberculosis meningitis and have not yet started more than 5 days of TB treatment.
AbidjanAges 15 years+ - NCT04194372Recruiting
Health study of risk markers in people with metabolic conditions
This study looks at your health “risk profile” in a hospital group of people with metabolic conditions like diabetes, obesity, or metabolic syndrome. It mainly focuses on measuring factors to better understand who is at higher risk of health problems over time.
Boulogne-sur-MerAges 18 years+ - NCT04445285RecruitingPhase 2
Test drops to thin lung mucus in severe COVID-19
This Phase 2 trial tests rhDNase (a medication similar to Pulmozyme) to improve outcomes and reduce the risk of death in people with severe COVID-19 causing breathing failure. It’s meant for adults who need high-flow oxygen or a breathing machine.
Mobile, AlabamaAges 18 years+ - NCT04588311RecruitingPhase 3
Epoetin to improve outcomes in severe trauma ICU patients
This trial tests epoetin alfa (a blood-building medicine) to help reduce death and severe disability in critically ill trauma patients in the ICU. You may be considered if your ICU team expects a longer stay and the timing after injury is early.
Camperdown, New South WalesAges 18–75 - NCT04663893Recruiting
Study of fractures around implants after injury or surgery
This study looks at how often certain shoulder, elbow, hip, and knee fractures happen around orthopedic hardware (implants), and how they affect recovery and outcomes. Results may help doctors choose better treatment and predict risks for patients with these fracture types.
BarcelonaAges 18 years+ - NCT04662918Recruiting
Test the CAGIB score to predict death in cirrhosis with bleeding
This study checks whether a score called CAGIB can accurately predict the risk of dying during the hospital stay for people with cirrhosis who have sudden bleeding in the digestive tract. It may help doctors identify who needs the most urgent care and monitor outcomes more accurately.
Scranton, PennsylvaniaAges 18 years+ - NCT04664556Recruiting
Study of severe pneumococcal infections in children
This study tracks cases of invasive pneumococcal disease (a serious infection) in children and newborns. It may help clinicians better understand how these infections happen and guide future prevention and treatment.
CréteilAges 1 day–18 years - NCT04800393Recruiting
Breast surgery anesthesia and its effects on immunity and survival
This study compares two ways of giving anesthesia during breast cancer surgery to see how they affect the immune system and outcomes after surgery. It may help identify which anesthesia approach is better for people like you having early-stage, operable breast cancer surgery.
MoscowAges 45–74
Hear when a new Mortality trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for mortality?
- Yes. Clin2 currently lists 155 recruiting mortality studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a mortality trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a mortality trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.